The Application of Intrapleural Dornase Alfa Alone in a Pediatric Case
Yıl: 2021 Cilt: 29 Sayı: 4 Sayfa Aralığı: 210 - 212 Metin Dili: İngilizce DOI: 10.5336/caserep.2021-81089 İndeks Tarihi: 29-06-2022
The Application of Intrapleural Dornase Alfa Alone in a Pediatric Case
Öz: The treatment of empyema in children is controversial. In both children and adults, in addition to empyema drainage and parenteral
antibiotics, it has been reported that treatments of intrapleural dornase alfa alone or in combination with fibrinolytic agents have been used successfully. Although fibrinolytic treatment seems to be less invasive, it may cause traumatic or intolerable side-effects in young children. There
are some reports in the literature about the efficacy of intrapleural dornase alfa used alone in the treatment adults with empyema. To best of our
knowledge, there are no data related to children. In this case report, a 6-year old girl, diagnosed with empyema, resistant to intravenous antibiotics and tube drainage, treated with intrapleural dornase alfa alone, was presented.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
- 1. Chibuk T, Cohen E, Robinson J, Mahant S, Hartfield D. Paediatric complicated pneumonia: Diagnosis and management of empyema. Paediatr Child Health. 2011;16(7):425-9. [PubMed] [PMC]
- 2. Livingston MH, Mahant S, Ratjen F, Connolly BL, Thorpe K, Mamdani M, et al. Intrapleural dornase and tissue plasminogen activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial. Trials. 2017;18(1):293. [Crossref] [PubMed] [PMC]
- 3. Goralski JL, Bromberg PA, Haithcock B. Intrapleural hemorrhage after administration of tPA: a case report and review of the literature. Ther Adv Respir Dis. 2009;3(6):295-300. [Crossref] [PubMed]
- 4. Gehlen M, Fraga JC, Amantea SL, Silveira NP, Kulczynski J, Roesch E, et al. Alteplase and DNase for the treatment of pleural empyema in rats. Pulm Pharmacol Ther. 2019;55:1-4. [Crossref] [PubMed]
- 5. Bobek V, Majewski A, Kolostova K, Rzechonek A, Lischke R, Schutzner J, et al. Intrapleural administration of DNase alone for pleural empyema. Int J Clin Exp Med. 2015; 8(11):22011-5. [PubMed] [PMC]
- 6. Eckhart L, Fischer H, Barken KB, Tolker-Nielsen T, Tschachler E. DNase1L2 suppresses biofilm formation by Pseudomonas aeruginosa and Staphylococcus aureus. Br J Dermatol. 2007; 156(6):1342-5. [Crossref] [PubMed]
- 7. Dentice R, Elkins M. Timing of dornase alfa inhalation for cystic fibrosis. Cochrane Database Syst Rev. 2016;7(7):CD007923. [Crossref] [PubMed] [PMC]
- 8. Luengo-Fernandez R, Penz E, Dobson M, Psallidas I, Nunn AJ, Maskell NA, et al. Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: evidence from the MIST2 randomised controlled trial. Eur Respir J. 2019; 54(2):1801550. [Crossref] [PubMed]
- 9. Hart JA, Badiei A, Lee YCG. Successful management of pleural infection with very low dose intrapleural tissue plasminogen activator/deoxyribonuclease regime. Respirol Case Rep. 2019;7(3):e00408. [Crossref] [PubMed] [PMC]
- 10. Rahman NM, Maskell NA, West A, Teoh R, Arnold A, Mackinlay C, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365:518-26. [Crossref] [PubMed]
| APA | Udurgucu M, Albayrak H, Kınık kaya H, Yener N (2021). The Application of Intrapleural Dornase Alfa Alone in a Pediatric Case. , 210 - 212. 10.5336/caserep.2021-81089 |
| Chicago | Udurgucu Muhammed,Albayrak Hatice,Kınık kaya Hatıce elıf,Yener Nazik The Application of Intrapleural Dornase Alfa Alone in a Pediatric Case. (2021): 210 - 212. 10.5336/caserep.2021-81089 |
| MLA | Udurgucu Muhammed,Albayrak Hatice,Kınık kaya Hatıce elıf,Yener Nazik The Application of Intrapleural Dornase Alfa Alone in a Pediatric Case. , 2021, ss.210 - 212. 10.5336/caserep.2021-81089 |
| AMA | Udurgucu M,Albayrak H,Kınık kaya H,Yener N The Application of Intrapleural Dornase Alfa Alone in a Pediatric Case. . 2021; 210 - 212. 10.5336/caserep.2021-81089 |
| Vancouver | Udurgucu M,Albayrak H,Kınık kaya H,Yener N The Application of Intrapleural Dornase Alfa Alone in a Pediatric Case. . 2021; 210 - 212. 10.5336/caserep.2021-81089 |
| IEEE | Udurgucu M,Albayrak H,Kınık kaya H,Yener N "The Application of Intrapleural Dornase Alfa Alone in a Pediatric Case." , ss.210 - 212, 2021. 10.5336/caserep.2021-81089 |
| ISNAD | Udurgucu, Muhammed vd. "The Application of Intrapleural Dornase Alfa Alone in a Pediatric Case". (2021), 210-212. https://doi.org/10.5336/caserep.2021-81089 |
| APA | Udurgucu M, Albayrak H, Kınık kaya H, Yener N (2021). The Application of Intrapleural Dornase Alfa Alone in a Pediatric Case. Türkiye Klinikleri Journal of Case Reports, 29(4), 210 - 212. 10.5336/caserep.2021-81089 |
| Chicago | Udurgucu Muhammed,Albayrak Hatice,Kınık kaya Hatıce elıf,Yener Nazik The Application of Intrapleural Dornase Alfa Alone in a Pediatric Case. Türkiye Klinikleri Journal of Case Reports 29, no.4 (2021): 210 - 212. 10.5336/caserep.2021-81089 |
| MLA | Udurgucu Muhammed,Albayrak Hatice,Kınık kaya Hatıce elıf,Yener Nazik The Application of Intrapleural Dornase Alfa Alone in a Pediatric Case. Türkiye Klinikleri Journal of Case Reports, vol.29, no.4, 2021, ss.210 - 212. 10.5336/caserep.2021-81089 |
| AMA | Udurgucu M,Albayrak H,Kınık kaya H,Yener N The Application of Intrapleural Dornase Alfa Alone in a Pediatric Case. Türkiye Klinikleri Journal of Case Reports. 2021; 29(4): 210 - 212. 10.5336/caserep.2021-81089 |
| Vancouver | Udurgucu M,Albayrak H,Kınık kaya H,Yener N The Application of Intrapleural Dornase Alfa Alone in a Pediatric Case. Türkiye Klinikleri Journal of Case Reports. 2021; 29(4): 210 - 212. 10.5336/caserep.2021-81089 |
| IEEE | Udurgucu M,Albayrak H,Kınık kaya H,Yener N "The Application of Intrapleural Dornase Alfa Alone in a Pediatric Case." Türkiye Klinikleri Journal of Case Reports, 29, ss.210 - 212, 2021. 10.5336/caserep.2021-81089 |
| ISNAD | Udurgucu, Muhammed vd. "The Application of Intrapleural Dornase Alfa Alone in a Pediatric Case". Türkiye Klinikleri Journal of Case Reports 29/4 (2021), 210-212. https://doi.org/10.5336/caserep.2021-81089 |
